» Articles » PMID: 38397097

The Role of the Endocrine System in the Regulation of Acid-Base Balance by the Kidney and the Progression of Chronic Kidney Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 24
PMID 38397097
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic acid-base status is primarily determined by the interplay of net acid production (NEAP) arising from metabolism of ingested food stuffs, buffering of NEAP in tissues, generation of bicarbonate by the kidney, and capture of any bicarbonate filtered by the kidney. In chronic kidney disease (CKD), acid retention may occur when dietary acid production is not balanced by bicarbonate generation by the diseased kidney. Hormones including aldosterone, angiotensin II, endothelin, PTH, glucocorticoids, insulin, thyroid hormone, and growth hormone can affect acid-base balance in different ways. The levels of some hormones such as aldosterone, angiotensin II and endothelin are increased with acid accumulation and contribute to an adaptive increase in renal acid excretion and bicarbonate generation. However, the persistent elevated levels of these hormones can damage the kidney and accelerate progression of CKD. Measures to slow the progression of CKD have included administration of medications which inhibit the production or action of deleterious hormones. However, since metabolic acidosis accompanying CKD stimulates the secretion of several of these hormones, treatment of CKD should also include administration of base to correct the metabolic acidosis.

Citing Articles

Acid-Base Balance in Healthy Adults: Beneficial Effects of Bicarbonate and Sodium-Rich Mineral Water in a Randomized Controlled Trial: The BicarboWater Study.

Mansouri K, Greupner T, van de Flierdt E, Schneider I, Hahn A J Nutr Metab. 2024; 2024:3905500.

PMID: 39263192 PMC: 11390205. DOI: 10.1155/2024/3905500.


Endocrine Disorders in Nephrotic Syndrome-A Comprehensive Review.

Mizdrak M, Smajic B, Mizdrak I, Kurir T, Kumric M, Paladin I Biomedicines. 2024; 12(8).

PMID: 39200324 PMC: 11351826. DOI: 10.3390/biomedicines12081860.


Metabolic alkalosis in cystic fibrosis: from vascular volume depletion to impaired bicarbonate excretion.

Soleimani M Front Endocrinol (Lausanne). 2024; 15:1411317.

PMID: 39170739 PMC: 11335532. DOI: 10.3389/fendo.2024.1411317.


Changes of Dissociative Properties of Hemoglobin in Patients with Chronic Kidney Disease.

Korus J, Wydro M, Golebiowski M, Krakowska K, Poznanski P, Musial K Diagnostics (Basel). 2024; 14(12).

PMID: 38928635 PMC: 11203233. DOI: 10.3390/diagnostics14121219.

References
1.
Lennon E, LEMANN Jr J, Litzow J . The effects of diet and stool composition on the net external acid balance of normal subjects. J Clin Invest. 1966; 45(10):1601-7. PMC: 292841. DOI: 10.1172/JCI105466. View

2.
Jehle S, Hulter H, Krapf R . On the mechanism of growth hormone-induced stimulation of renal acidification in humans: effect of dietary NaCl. Clin Sci (Lond). 2000; 99(1):47-56. View

3.
Nagami G . Role of angiotensin II in the enhancement of ammonia production and secretion by the proximal tubule in metabolic acidosis. Am J Physiol Renal Physiol. 2008; 294(4):F874-80. DOI: 10.1152/ajprenal.00286.2007. View

4.
Spoto B, Pisano A, Zoccali C . Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol. 2016; 311(6):F1087-F1108. DOI: 10.1152/ajprenal.00340.2016. View

5.
Szylman P, Better O, Chaimowitz C, Rosler A . Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med. 1976; 294(7):361-5. DOI: 10.1056/NEJM197602122940703. View